Loading…
IRIDEX Corporation is projected to rise to $1.30 by 2027, a +16% move from its current price of $1.12. IRIX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 6/10/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jun 11 | $1.09 | $1.12 | $1.15 | -0.01% |
| Jun 12 | $1.08 | $1.12 | $1.16 | -0.02% |
| Jun 13 | $1.07 | $1.12 | $1.17 | -0.03% |
| Jun 14 | $1.07 | $1.12 | $1.18 | -0.04% |
| Jun 15 | $1.06 | $1.12 | $1.18 | -0.06% |
| Jun 16 | $1.05 | $1.12 | $1.19 | -0.07% |
| Jun 17 | $1.05 | $1.12 | $1.19 | -0.08% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.05 | $1.12 | $1.19 | -0.08% |
| Week 2 | $1.02 | $1.12 | $1.23 | -0.16% |
| Week 3 | $0.9989 | $1.12 | $1.25 | -0.23% |
| Week 4 | $0.981 | $1.12 | $1.27 | -0.31% |
| Week 5 | $0.9654 | $1.12 | $1.29 | -0.39% |
| Week 6 | $0.9514 | $1.11 | $1.31 | -0.46% |
| Week 7 | $0.9387 | $1.11 | $1.32 | -0.54% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
IRIDEX Corporation is an ophthalmic medical technology company that provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. Its product lineup includes laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders.
In addition, it offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform transscleral laser therapy; G-Probe and G-Probe Illuminate, which are used in procedures to treat uncontrolled and refractory glaucoma; and EndoProbe family of products that are used for endophotocoagulation. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics through direct and independent sales force in the United States, as well as through independent distributors internationally. It operates in the United States, Europe, the Middle East, Africa, the Asia/Pacific region, and the Americas.
The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.
IRIDEX Corporation (IRIX) is the stock in focus, currently trading at $1.09. It has a market capitalization of $18.97M and ranks 4613. The near-term forecast suggests upside potential, with the 2030 average price projected at $1.73, the 2040 average at $2.83, and the 2050 average at $5.90.
The 2050 forecast also shows a max of $10.55, indicating a possible higher-price scenario in the long term. These figures point to a path of growth over the coming years, though they remain estimates rather than guarantees.
A major floor 17.6% below — a decisive break under it would weaken the trend.
The nearest floor, 10.7% below — buyers have tended to step in here.
The nearest ceiling, 4.5% above — a clean break opens room to run.
A major ceiling 33.9% above — clearing it would confirm fresh momentum.
Key IRIX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of IRIX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.13 | Sell | $1.11 | Buy |
| MA 10 | $1.09 | Buy | $1.10 | Buy |
| MA 20 | $1.06 | Buy | $1.08 | Buy |
| MA 50 | $1.04 | Buy | $1.09 | Buy |
| MA 100 | $1.22 | Sell | $1.14 | Sell |
| MA 200 | $1.17 | Sell | $1.18 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.74 | Neutral |
| Stoch RSI (14) | 54.74 | Neutral |
| CCI (20) | 80.25 | Neutral |
| Williams %R (14) | -35.29 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 11.00 | Buy |
| Bollinger %B (20,2) | 0.75 | Neutral |
| Stochastic %K (14) | 64.71 | Neutral |
| TRIX (15) | 0.07 | Buy |
| Awesome (5,34) | 0.08 | Buy |
| Ultimate (7,14,28) | 63.88 | Neutral |
| Momentum (10) | 0.10 | Buy |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 1.14 | Sell |
| ADX (14) | 16.49 | Neutral |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is bullish, with sentiment labeled as BULLISH and RSI14 at 50. The 50-day simple moving average sits at $1.05, while the 200-day simple moving average stands at $1.17. Support is identified at $1.00 and resistance at $1.17, framing a tight near-term trading range.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.95 | $1.12 | $1.40 | 0% | Neutral | |
| $1.04 | $1.30 | $1.71 | +16% | Neutral | |
| $1.19 | $1.52 | $2.07 | +36% | Bullish | |
| $1.30 | $1.70 | $2.37 | +51% | Bullish | |
| $1.38 | $1.83 | $2.60 | +63% | Bullish | |
| $1.29 | $1.73 | $2.52 | +55% | Bullish | |
| $1.36 | $1.86 | $2.75 | +66% | Bullish | |
| $1.48 | $2.05 | $3.08 | +83% | Bullish | |
| $1.52 | $2.14 | $3.26 | +91% | Bullish | |
| $1.82 | $2.60 | $4.02 | +132% | Bullish | |
| $2.03 | $3.07 | $5.02 | +174% | Bullish | |
| $3.84 | $6.40 | $11.38 | +472% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| June 2026 | $0.95 | $1.12 | $1.33 | +0.00% |
| July 2026 | $0.931 | $1.10 | $1.32 | -2.14% |
| August 2026 | $0.9358 | $1.11 | $1.35 | +1.16% |
| September 2026 | $0.9603 | $1.14 | $1.41 | +3.14% |
| October 2026 | $0.9427 | $1.13 | $1.40 | -1.37% |
| November 2026 | $0.9149 | $1.10 | $1.37 | -2.55% |
| December 2026 | $0.9282 | $1.12 | $1.40 | +1.84% |
Click any year to see its month-by-month IRIX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The IRIX price prediction for 2026 points to an average of $1.12 (low $0.95, high $1.40) — a potential gain of 0% on today's $1.12. A consolidation phase looks the most probable path here.
In 2027, IRIX is projected to trade between $1.04 and $1.71, averaging $1.30 — a potential gain of +16% from today's $1.12. That is up +16% on the projected 2026 average. Price action looks broadly range-bound.
IRIDEX Corporation's 2028 outlook centres on $1.52, within a $1.19 to $2.07 range. That is up +17% on the projected 2027 average. That marks a +36% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, IRIX could reach as high as $2.37, with a base case around $1.70 and support toward $1.30 — roughly +51% from $1.12. Momentum favours further upside here.
Expect IRIX to range from $1.38 to $2.60 through 2030. The $1.83 average target implies a +63% move from current prices. That is up +8% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The IRIX price prediction for 2031 points to an average of $1.73 (low $1.29, high $2.52) — a potential gain of +55% on today's $1.12. Momentum favours further upside here.
In 2032, IRIX is projected to trade between $1.36 and $2.75, averaging $1.86 — a potential gain of +66% from today's $1.12. That is up +7% on the projected 2031 average. Buyers look set to stay in control over this stretch.
IRIDEX Corporation's 2033 outlook centres on $2.05, within a $1.48 to $3.08 range. That is up +10% on the projected 2032 average. That marks a +83% change versus current levels. Momentum favours further upside here.
By 2034, IRIX could reach as high as $3.26, with a base case around $2.14 and support toward $1.52 — roughly +91% from $1.12. Buyers look set to stay in control over this stretch.
Expect IRIX to range from $1.82 to $4.02 through 2035. The $2.60 average target implies a +132% move from current prices. That is up +21% on the projected 2034 average. Momentum favours further upside here.
The IRIX price prediction for 2040 points to an average of $3.07 (low $2.03, high $5.02) — a potential gain of +174% on today's $1.12. Buyers look set to stay in control over this stretch.
In 2050, IRIX is projected to trade between $3.84 and $11.38, averaging $6.40 — a potential gain of +472% from today's $1.12. That is up +109% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in IRIX today (≈ 892.857143 IRIX) could be worth
$5,716.39
+$4,716.39 (+472%) by 2050 · US Dollar
Based on the average projected IRIX price of $6.4 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in IRIXwould be worth at today's price.
$1,000 invested in IRIX on Jun 9, 2025 (≈ 1,010.101 IRIX) would be worth
$1,131.31
+$131.31 (+13.1%) today · 1.13× · US Dollar
Based on a IRIX entry price of $0.99 vs. today's $1.12.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.11 | $1,009.01 | +0.9% |
| 1 month ago | $1.03 | $1,087.38 | +8.7% |
| 3 months ago | $1.34 | $835.82 | -16.4% |
| 6 months ago | $0.94 | $1,191.49 | +19.1% |
| 1 year ago | $0.99 | $1,131.31 | +13.1% |
| All time (5.0y) ago | $7.74 | $144.7 | -85.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our IRIX forecast.
Our base-case forecast reaches $2.20 around 2035.
Implied market cap at $2.20: $38.29M
The multi-year forecast outlines a trajectory of gradual price expansion through 2030 and beyond. In 2026 the average is forecast at $1.09 with a neutral sentiment and 0% ROI. By 2027, the average rises to $1.25 (ROI 14.4%), and 2028 sees an average of $1.46 (ROI 33.9%).
The 2030 average is $1.73 (ROI 59.1%), continuing to 2031 ($1.64, ROI 50.6%), 2032 ($1.76, ROI 61.1%), 2033 ($1.92, ROI 76.5%), 2034 ($1.99, ROI 82.9%), and 2035 ($2.43, ROI 123.2%). The forecast then climbs to 2040 with an average of $2.83 (ROI 160) and culminates in 2050 at an average of $5.90 (ROI 441.2%), with a max of $10.55. The sentiment broadens to bullish across the later years.
These are estimates and not guarantees; actual results depend on market conditions and other factors.
Tap a question to reveal the answer.
Avg $1.73; min $1.30; max $2.48; ROI 59.1%; sentiment BULLISH.
Forecasts show a bullish path in the later years, with 2027 avg $1.25 (ROI 14.4%), 2028 avg $1.46 (ROI 33.9%), 2030 avg $1.73 (ROI 59.1%), and 2050 avg $5.90 (ROI 441.2%). 2026 is neutral with an avg of $1.09 and ROI of 0%.
Yes—the 2050 max forecast is $10.55.
Current price is $1.09 and market cap is $18.97M.
Low $0.9251 and high $1.28.
IRIDEX Corporation Community Discussion
0Share your IRIDEX Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.